Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab (vol 115, pg 71, 2018)

被引：3
|
作者：
Sato, Koichi [1 ]
Akamatsu, Hiroaki [1 ]
Murakami, Eriko [1 ]
Sasaki, Seigo [1 ]
Kanai, Kuninobu [1 ]
Hayata, Atsushi [1 ]
Tokudome, Nahomi [1 ]
Akamatsu, Keiichiro [1 ]
Koh, Yasuhiro [1 ]
Ueda, Hiroki [1 ]
Nakanishi, Masanori [1 ]
Yamamoto, Nobuyuki [1 ]
机构：
[1] Wakayama Med Univ, Dept Internal Med 3, Wakayama, Japan
来源：
LUNG CANCER | 2018年 / 126卷
关键词：
D O I：
10.1016/j.lungcan.2018.11.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：230 / 231
页数：2
相关论文
共 50 条
  • [21] Immune-Related Adverse Events and Outcomes in Patients with Advanced Non-Small Cell Lung Cancer: A Predictive Marker of Efficacy?
    Remon, Jordi
    Reguart, Noemi
    Auclin, Edouard
    Besse, Benjamin
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (06) : 963 - 967
  • [22] Association of Immune-Related Adverse Events with Clinical Benefit in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Nivolumab
    Toi, Yukihiro
    Sugawara, Shunichi
    Kawashima, Yosuke
    Aiba, Tomoiki
    Kawana, Sachiko
    Saito, Ryohei
    Tsurumi, Kyoji
    Suzuki, Kana
    Shimizu, Hisashi
    Sugisaka, Jun
    Ono, Hirotaka
    Domeki, Yutaka
    Terayama, Keisuke
    Nakamura, Atsushi
    Yamanda, Shinsuke
    Kimura, Yuichiro
    Honda, Yoshihiro
    ONCOLOGIST, 2018, 23 (11): : 1358 - 1365
  • [23] Association Between Immune-related Adverse Events and Efficacy of Immune Checkpoint Inhibitors in Non-small-cell Lung Cancer
    Grangeon, Mathieu
    Tomasini, Pascale
    Chaleat, Solene
    Jeanson, Arnaud
    Souquet-Bressand, Maxime
    Khobta, Nataliya
    Bermudez, Julien
    Trigui, Youssef
    Greillier, Laurent
    Blanchon, Marilyne
    Boucekine, Mohamed
    Mascaux, Celine
    Barlesi, Fabrice
    CLINICAL LUNG CANCER, 2019, 20 (03) : 201 - 207
  • [24] Clinical Association Between Immune-related Adverse Events and Treatment Efficacy in Patients With Non-small-cell Lung Cancer Treated With Nivolumab-Ipilimumab-based Therapy
    Ebi, Noriyuki
    Inoue, Hiroyuki
    Igata, Fumiyasu
    Okuma, Rei
    Kinoshita, Eriko
    Kawabata, Toshiaki
    Tan, Ibun
    Osaki, Yusuke
    Ikeda, Takato
    Nakao, Akira
    Shundo, Yuki
    Hamada, Naoki
    Fujita, Masaki
    ANTICANCER RESEARCH, 2024, 44 (07) : 3087 - 3095
  • [25] Association Between Early Immune-related Adverse Events and Clinical Outcomes in Patients With Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
    Hosoya, Kazutaka
    Fujimoto, Daichi
    Morimoto, Takeshi
    Kumagai, Toru
    Tamiya, Akihiro
    Taniguchi, Yoshihiko
    Yokoyama, Toshihide
    Ishida, Tadashi
    Hirano, Katsuya
    Matsumoto, Hirotaka
    Kominami, Ryota
    Tomii, Keisuke
    Suzuki, Hidekazu
    Hirashima, Tomonori
    Uchida, Junji
    Morita, Mitsunori
    Kanazu, Masaki
    Sawa, Nobuhiko
    Makio, Takeshi
    Hara, Satoshi
    Tamiya, Motohiro
    CLINICAL LUNG CANCER, 2020, 21 (04) : E315 - E328
  • [26] Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab.
    Masuda, Ken
    Shoji, Hirokazu
    Nagashima, Kengo
    Yamamoto, Shun
    Ishikawa, Masashi
    Imazeki, Hiroshi
    Aoki, Masahiko
    Miyamoto, Takahiro
    Hirano, Hidekazu
    Honma, Yoshitaka
    Iwasa, Satoru
    Okita, Natsuko
    Takashima, Atsuo
    Kato, Ken
    Boku, Narikazu
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [27] Correlation between immune-related adverse events and prognosis in renal cell carcinoma patients treated with nivolumab
    Kato, Taigo
    Nagahara, Akira
    Kawamura, Norihiko
    Nakata, Wataru
    Soda, Tetsuji
    Matsuzaki, Kyosuke
    Hatano, Koji
    Kawashima, Atsunari
    Ujike, Takeshi
    Imamura, Ryoichi
    Nishimura, Kensaku
    Takada, Shingo
    Tsujihata, Masao
    Yamaguchi, Seiji
    Takao, Tetsuya
    Nishimura, Kazuo
    Uemura, Motohide
    Nonomura, Norio
    ANNALS OF ONCOLOGY, 2021, 32 : S314 - S314
  • [28] Correlation of immune-related adverse events and response from immune checkpoint inhibitors in patients with advanced non-small cell lung cancer
    Sung, Mike
    Zer, Mona
    Walia, Preet
    Khoja, Leila
    Maganti, Manjula
    Labbe, Catherine
    Shepherd, Frances A.
    Bradbury, Penelope A.
    Liu, Geoffrey
    Leighl, Natasha B.
    JOURNAL OF THORACIC DISEASE, 2020, 12 (05) : 2706 - 2712
  • [29] Immune-related adverse events correlate with clinical outcomes in non-small cell lung cancer (NSCLC) patients treated with nivolumab in the Italian expanded access programme
    Baldini, E.
    Lunghi, A.
    Cortesi, E.
    Turci, D.
    Garassino, M. C.
    Stati, V.
    Ardizzoni, A.
    Ricciuti, B.
    Frassoldati, A.
    Romano, G.
    Illiano, A.
    Verderame, F.
    Fasola, G.
    Marchetti, P.
    Pinto, C.
    Carteni, G.
    Scotti, V.
    Tibaldi, C.
    Fioretto, L.
    Giannarelli, D.
    ANNALS OF ONCOLOGY, 2018, 29
  • [30] Association Between Immune-Related Adverse Events and Survival in a Contemporary Metastatic Non-Small Cell Lung Cancer Cohort
    Cook, S.
    Samuel, V.
    Meyers, D.
    Stukalin, I.
    Litt, I.
    Sangha, R.
    Morris, D.
    Heng, D.
    Pabani, A.
    Navani, V.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S308 - S308
12345